3 Followers SGX:BFK - Pharmesis International Ltd Pharmesis Intl
Sector: Health Care, Industry: Pharmaceuticals
Add to Watchlist
Add Alert 

Yahoo Finance See related symbol P31

SGD 0.147    +0.0 (+0%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

21 Jan 2022



CEO: Mr. Jie Qi

Headquarters: SG

Employees: 0



Pharmesis International Ltd is an investment holding company. It manufactures pharmaceutical products in the form of tablets, granules, pills, and other forms. Its geographical segments are Western drugs, which are chemically formulated drugs and are marketed under the Kinna brand; TCM formulated drugs, which refer to Traditional Chinese Medicine and are marketed under the Longlife brand; and Distribution. The company derives revenue from the sale of medicines to domestic customers in China.